Page last updated: 2024-08-25

bendamustine hydrochloride and Tumor Lysis Syndrome

bendamustine hydrochloride has been researched along with Tumor Lysis Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Assouline, S; Boyer, M; Cartron, G; D'Rozario, J; De la Serna, J; Eichhorst, B; Gerecitano, J; Hillmen, P; Humerickhouse, R; Humphrey, K; Jaeger, U; Kater, AP; Kipps, TJ; Li, Y; Mobasher, M; Montillo, M; Owen, C; Punnoose, EA; Robak, T; Seymour, JF	1
Held-Warmkessel, J	1
Adam, K; Bergmann, J; Buchheidt, D; Hehlmann, R; Hummel, M; Reiter, S	1

Trials

1 trial(s) available for bendamustine hydrochloride and Tumor Lysis Syndrome

Article	Year
Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia. The New England journal of medicine, 2018, Mar-22, Volume: 378, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bridged Bicyclo Compounds, Heterocyclic; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm, Residual; Neutropenia; Recurrence; Rituximab; Sulfonamides; Tumor Lysis Syndrome; Young Adult	2018

Article

Year

Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.

The New England journal of medicine, 2018, Mar-22, Volume: 378, Issue:12

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bridged Bicyclo Compounds, Heterocyclic; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm, Residual; Neutropenia; Recurrence; Rituximab; Sulfonamides; Tumor Lysis Syndrome; Young Adult

2018

Other Studies

2 other study(ies) available for bendamustine hydrochloride and Tumor Lysis Syndrome

Article	Year
A patient with tumor lysis syndrome. Oncology (Williston Park, N.Y.), 2012, Volume: 26, Issue:8 Suppl Nu Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Drug Interactions; Drug Monitoring; Humans; Male; Middle Aged; Nitrogen Mustard Compounds; Practice Guidelines as Topic; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase	2012
Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase. European journal of haematology, 2005, Volume: 75, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Creatinine; Cyclophosphamide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nitrogen Mustard Compounds; Recombinant Proteins; Renal Insufficiency; Tumor Lysis Syndrome; Urate Oxidase; Uric Acid; Vidarabine	2005

Article

Year

A patient with tumor lysis syndrome.

Oncology (Williston Park, N.Y.), 2012, Volume: 26, Issue:8 Suppl Nu

Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Drug Interactions; Drug Monitoring; Humans; Male; Middle Aged; Nitrogen Mustard Compounds; Practice Guidelines as Topic; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase

2012

Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.

European journal of haematology, 2005, Volume: 75, Issue:6

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Creatinine; Cyclophosphamide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nitrogen Mustard Compounds; Recombinant Proteins; Renal Insufficiency; Tumor Lysis Syndrome; Urate Oxidase; Uric Acid; Vidarabine

2005